Neuren Pharmaceuticals
€7.05
46
+€0.35+5.22% Thursday 06:05
Statistics
Day High
6.7
Day Low
6.7
52W High
11.3
52W Low
4.26
Volume
3,000
Avg. Volume
-
Mkt Cap
892.81M
P/E Ratio
50.36
Dividend Yield
-
Dividend
-
Upcoming
Earnings
25FebExpected
Expected EPS
0.007624625715
Actual EPS
0.066870791456
Financials
48.23%Profit Margin
Profitable78MRevenue
37.62MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NK9.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.78B
Biogen
BIIB
Mkt Cap26.03B
PTC Therapeutics
PTCT
Mkt Cap5.4B
Ionis Pharmaceuticals
IONS
Mkt Cap12.35B
Alnylam Pharmaceuticals
ALNY
Mkt Cap42.29B
Anavex Life Sciences
AVXL
Mkt Cap277.09M
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
About
Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia.
Show more...
CEO
Mr. Jonathan Charles Pilcher A.C.A., B.Sc., BSc (Hons), F.C.A.
Country
DE
ISIN
NZNEUE0001S8
WKN
000A0DPHQ
Listings
0 Comments
Share your thoughts
FAQ
What is Neuren Pharmaceuticals stock price today?▼
The current price of NK9.F is €7.05 EUR — it has increased by +5.22% in the past 24 hours. Watch Neuren Pharmaceuticals stock price performance more closely on the chart.
What is Neuren Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuren Pharmaceuticals stocks are traded under the ticker NK9.F.
Is Neuren Pharmaceuticals stock price growing?▼
NK9.F stock has risen by +5.22% compared to the previous week, the month change is a -2.76% fall, over the last year Neuren Pharmaceuticals has showed a +58.78% increase.
What is Neuren Pharmaceuticals market cap?▼
Today Neuren Pharmaceuticals has the market capitalization of 892.81M
When is the next Neuren Pharmaceuticals earnings date?▼
Neuren Pharmaceuticals is going to release the next earnings report on August 25, 2026.
What were Neuren Pharmaceuticals earnings last quarter?▼
NK9.F earnings for the last quarter are 0.07 EUR per share, whereas the estimation was 0.01 EUR resulting in a +777.04% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Neuren Pharmaceuticals revenue for the last year?▼
Neuren Pharmaceuticals revenue for the last year amounts to 78M EUR.
What is Neuren Pharmaceuticals net income for the last year?▼
NK9.F net income for the last year is 37.62M EUR.
When did Neuren Pharmaceuticals complete a stock split?▼
The last stock split for Neuren Pharmaceuticals was on November 21, 2017 with a ratio of 1:20.
Where is Neuren Pharmaceuticals headquartered?▼
Neuren Pharmaceuticals is headquartered in Hawthorn East, DE.